Self-Management Training Among Individuals With TBI

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-100
SponsorBoston University Charles River Campus

About this trial

Traumatic brain injury (TBI) can have long-term and chronic effects on an individual's physical, social, and emotional health, impacting quality of life and the ability to engage in meaningful life roles. Despite the potential for long-term effects, much of the care for individuals with TBI is front-loaded in the weeks to months post-injury. Self-management and self-management training are key components of long-term care for many chronic health conditions, but they are not standard parts of care for individuals with TBI.

In this study the investigators will address two objectives: 1) identify self-management priorities from the perspectives of individuals with chronic TBI, families, and health care providers and 2) pilot test an existing virtual community-based self-management training program (the Chronic Disease Self-Management Program (CDMSP)), to a) evaluate changes in quality of life, self-management self-efficacy, and other patient-reported outcomes before and after participating in the training, and b) identify barriers and facilitators to participating in community-based self-management training.

Eligibility criteria

Qualifiers

Aged ≥18 years at time of first TBI

At least one year since the most recent TBI

Received care at BMC's Concussion/TBI program for a TBI or concussion

At least partially involved in Self-care

Disqualifiers

• Aged <18 at the time of their first TBI

Severe mental, cognitive, social, or emotional difficulties due to another neurologic, developmental, psychological condition, or active substance use disorder

Participating in another interventional clinical trial

Planned major surgery in the next 4 months.

Trial design

Treatments tested in this trial

  • Participants will be referred to a community based self-management training program

Treatment groups

85 Participants
are divided into 1 treatment group

Locations

This trial has no locations